{"id":"W1966162777","doi":"10.1097/jto.0b013e3181f49c22","title":"Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL)","year":2010,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Medicine; Gemcitabine; Placebo; Clinical endpoint; Hazard ratio; Internal medicine; Lung cancer; Oncology; Phases of clinical research; Chemotherapy; Surgery; Gastroenterology; Randomized controlled trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222977,0.0006543326,0.001776561,0.0002569912,0.0002225532,0.0007722515,0.0004960761,0.000684934,0.001445576],"category_scores_gemma":[0.0009388583,0.000271144,0.001376112,0.0003673329,0.000419237,0.0005786689,0.0002964666,0.001505521,0.0003231397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008789301,"about_ca_system_score_gemma":0.0008488598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00187733,"about_ca_topic_score_gemma":0.005332013,"domain_scores_codex":[0.9996918,0.000146872,0.0000180755,0.00004511372,0.00003648414,0.00006158487],"domain_scores_gemma":[0.9995963,0.0000833774,0.0001081641,0.00002227964,0.0000295007,0.0001603244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7661761,0.006691178,0.04783574,0.001079311,0.005335659,0.0001917753,0.0001907538,0.002564893,0.01821284,0.0002603262,0.00629139,0.1451701],"study_design_scores_gemma":[0.5176682,0.22917,0.2330113,0.0001779443,0.005900735,0.0004768375,0.0001554029,0.002451906,0.00283931,0.0003845515,0.007682938,0.00008095016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921807,0.00544378,0.00012003,0.0003274044,0.00006564632,0.0001361446,0.0007899358,0.00002126247,0.0009150442],"genre_scores_gemma":[0.9931672,0.002525351,0.0003516041,0.0005488706,0.0001428013,0.0002265357,0.002129458,0.00001430495,0.0008939373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00187733,"threshold_uncertainty_score":0.006467819,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01408119831461073,"score_gpt":0.4202527993054573,"score_spread":0.4061716009908466,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}